share_log

Abbisko to Publish Results of Tenosynovial Tumor Medication Phase 1B Trial at Meeting in Canada

Abbisko to Publish Results of Tenosynovial Tumor Medication Phase 1B Trial at Meeting in Canada

阿比斯科将在加拿大的会议上公布腱滑膜肿瘤药物1B期试验的结果
MT Newswires ·  2022/11/15 01:32

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发